Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 2016; Volume 89,Issue 1

Minireview

  • You have access
    Biochemical Pharmacology of the Sigma-1 Receptor
    Uyen B. Chu and Arnold E. Ruoho
    Molecular Pharmacology January 2016, 89 (1) 142-153; DOI: https://doi.org/10.1124/mol.115.101170

Articles

  • Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and <em>N</em>-Desbutyl Dronedarone
    You have access
    Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone
    Yanjun Hong, Yvonne Mei Fen Chia, Ray Hng Yeo, Gopalakrishnan Venkatesan, Siew Kwan Koh, Christina Li Lin Chai, Lei Zhou, Pipin Kojodjojo and Eric Chun Yong Chan
    Molecular Pharmacology January 2016, 89 (1) 1-13; DOI: https://doi.org/10.1124/mol.115.100891
  • You have access
    The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety
    Sang Jun Han, Khurshida Begum, Charles E. Foulds, Ross A. Hamilton, Suzanna Bailey, Anna Malovannaya, Doug Chan, Jun Qin and Bert W. O’Malley
    Molecular Pharmacology January 2016, 89 (1) 14-26; DOI: https://doi.org/10.1124/mol.115.100925
  • You have access
    Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism
    Logeswari Ponnusamy, Prathap Kumar S. Mahalingaiah and Kamaleshwar P. Singh
    Molecular Pharmacology January 2016, 89 (1) 27-41; DOI: https://doi.org/10.1124/mol.115.100206
  • You have access
    Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins
    Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala
    Molecular Pharmacology January 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
  • You have access
    Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination
    Amelia M. Huehls, Catherine J. Huntoon, Poorval M. Joshi, Carly A. Baehr, Jill M. Wagner, Xiaoxiao Wang, Marietta Y. Lee and Larry M. Karnitz
    Molecular Pharmacology January 2016, 89 (1) 53-62; DOI: https://doi.org/10.1124/mol.115.100164
  • Axon-to-Glia Interaction Regulates GABA<sub>A</sub> Receptor Expression in Oligodendrocytes
    You have access
    Axon-to-Glia Interaction Regulates GABAA Receptor Expression in Oligodendrocytes
    Rogelio O. Arellano, María Victoria Sánchez-Gómez, Elena Alberdi, Manuel Canedo-Antelo, Juan Carlos Chara, Aitor Palomino, Alberto Pérez-Samartín and Carlos Matute
    Molecular Pharmacology January 2016, 89 (1) 63-74; DOI: https://doi.org/10.1124/mol.115.100594
  • You have access
    Gβγ Binds to the Extreme C Terminus of SNAP25 to Mediate the Action of Gi/o-Coupled G Protein–Coupled Receptors
    Zack Zurawski, Shelagh Rodriguez, Karren Hyde, Simon Alford and Heidi E. Hamm
    Molecular Pharmacology January 2016, 89 (1) 75-83; DOI: https://doi.org/10.1124/mol.115.101600
  • You have access
    Reduced Myelination and Increased Glia Reactivity Resulting from Severe Neonatal Hyperbilirubinemia
    Andreia Barateiro, Shujuan Chen, Mei-Fei Yueh, Adelaide Fernandes, Helena Sofia Domingues, João Relvas, Olivier Barbier, Nghia Nguyen, Robert H. Tukey and Dora Brites
    Molecular Pharmacology January 2016, 89 (1) 84-93; DOI: https://doi.org/10.1124/mol.115.098228
  • You have access
    Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms
    Richard Carr, Cynthia Koziol-White, Jie Zhang, Hong Lam, Steven S. An, Gregory G. Tall, Reynold A. Panettieri and Jeffrey L. Benovic
    Molecular Pharmacology January 2016, 89 (1) 94-104; DOI: https://doi.org/10.1124/mol.115.100339
  • You have access
    A Small Molecule Pyrazolo[3,4-d]Pyrimidinone Inhibitor of Zipper-Interacting Protein Kinase Suppresses Calcium Sensitization of Vascular Smooth Muscle
    Justin A. MacDonald, Cindy Sutherland, David A. Carlson, Sabreena Bhaidani, Abdulhameed Al-Ghabkari, Karl Swärd, Timothy A. J. Haystead and Michael P. Walsh
    Molecular Pharmacology January 2016, 89 (1) 105-117; DOI: https://doi.org/10.1124/mol.115.100529
  • You have access
    Phosphorylation of RS1 (RSC1A1) Steers Inhibition of Different Exocytotic Pathways for Glucose Transporter SGLT1 and Nucleoside Transporter CNT1, and an RS1-Derived Peptide Inhibits Glucose Absorption
    Maike Veyhl-Wichmann, Alexandra Friedrich, Alexandra Vernaleken, Smriti Singh, Helmut Kipp, Valentin Gorboulev, Thorsten Keller, Chakravarthi Chintalapati, Rüdiger Pipkorn, Marçal Pastor-Anglada, Jürgen Groll and Hermann Koepsell
    Molecular Pharmacology January 2016, 89 (1) 118-132; DOI: https://doi.org/10.1124/mol.115.101162
  • Bumetanide Derivatives AqB007 and AqB011 Selectively Block the Aquaporin-1 Ion Channel Conductance and Slow Cancer Cell Migration
    You have access
    Bumetanide Derivatives AqB007 and AqB011 Selectively Block the Aquaporin-1 Ion Channel Conductance and Slow Cancer Cell Migration
    Mohamad Kourghi, Jinxin V. Pei, Michael L. De Ieso, Gary Flynn and Andrea J. Yool
    Molecular Pharmacology January 2016, 89 (1) 133-140; DOI: https://doi.org/10.1124/mol.115.101618
  • You have access
    CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver
    Ngome L. Makia and Joyce A. Goldstein
    Molecular Pharmacology January 2016, 89 (1) 154-164; DOI: https://doi.org/10.1124/mol.115.100255
  • You have access
    Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters
    Walter Sandtner, Thomas Stockner, Peter S. Hasenhuetl, John S. Partilla, Amir Seddik, Yuan-Wei Zhang, Jianjing Cao, Marion Holy, Thomas Steinkellner, Gary Rudnick, Michael H. Baumann, Gerhard F. Ecker, Amy Hauck Newman and Harald H. Sitte
    Molecular Pharmacology January 2016, 89 (1) 165-175; DOI: https://doi.org/10.1124/mol.115.101394
  • Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction
    You have access
    Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction
    M. Germana Sanna, Kevin P. Vincent, Emanuela Repetto, Nhan Nguyen, Steven J. Brown, Lusine Abgaryan, Sean W. Riley, Nora B. Leaf, Stuart M. Cahalan, William B. Kiosses, Yasushi Kohno, Joan Heller Brown, Andrew D. McCulloch, Hugh Rosen and Pedro J. Gonzalez-Cabrera
    Molecular Pharmacology January 2016, 89 (1) 176-186; DOI: https://doi.org/10.1124/mol.115.100222
  • You have access
    Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits
    Géza Berecki, Leonid Motin and David J. Adams
    Molecular Pharmacology January 2016, 89 (1) 187-196; DOI: https://doi.org/10.1124/mol.115.101154
  • You have access
    Identification and Validation of Larixyl Acetate as a Potent TRPC6 Inhibitor
    Nicole Urban, Liming Wang, Sandra Kwiek, Jörg Rademann, Wolfgang M. Kuebler and Michael Schaefer
    Molecular Pharmacology January 2016, 89 (1) 197-213; DOI: https://doi.org/10.1124/mol.115.100792

Errata

  • You have access
    Correction to “Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor”
    Molecular Pharmacology January 2016, 89 (1) 141; DOI: https://doi.org/10.1124/mol.115.098913err
  • You have access
    Correction to“The LRRC26 Protein Selectively Alters the Efficacy of BK Channel Activators”
    Molecular Pharmacology January 2016, 89 (1) 214; DOI: https://doi.org/10.1124/mol.115.075234err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 89 (1)
Molecular Pharmacology
Vol. 89, Issue 1
1 Jan 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics